Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/25 18:05 | 3/5/25 | JANX | Health | Drug | Pharmaceutical Preparations | Ra Capital Management, L.P. | MA | DT | 1 | P.m | 25,343 | 30.75 | 0 | 824 | 8 | 11,190 | I | |||||||||||||||
3/5/25 20:00 | 3/3/25 | JANX | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 6 | M.d | 1,208 | 33.05 | 0 | 37 | 80 | 82 | D | ||||||||||||||
3/5/25 20:00 | 3/3/25 | JANX | Health | Drug | Pharmaceutical Preparations | Meyer Andrew Hollman | CA | O | Chief Bu | 6 | S.d | -1,208 | 33.05 | 0 | -37 | 82 | D | |||||||||||||||
1/8/25 20:00 | 1/7/25 | JANX | Health | Drug | Pharmaceutical Preparations | Campbell David Alan | CA | DO | P,CEO | 2 | S | -1,705 | 56.83 | 0 | -30 | 293 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |